Opportunity
NOI - INOVA/NHLBI Biobanking in Hospitalized Patients
Response due
October 20, 2026
- Agency
- National Institutes of Health Olao
- Estimated value
- Not stated
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is PCA-NHLBI-04751. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Inova Health Care Services, 8095 Innovation Park Dr, Fairfax, VA 22031-4868, for the provision of access to patient samples and associated clinical data in support of the NHLBI Critical Care Research Program. Inova Fairfax Hospital is a local community hospital in close proximity to the NIH with an established infrastructure to consent, enroll, collect samples, and transfer samples to the NIH within 48 hours of patient admission, and this requirement is a renewal of an existing contract where pausing sample collection to establish equivalent infrastructure elsewhere would be detrimental to the program. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 622110, General Medical and Surgical Hospitals, and the small business size standard is $47 million in average annual receipts. This requirement is not set aside for small business.
Key dates
- Posted
- October 6, 2026
- Response due
- October 20, 2026
Who is this buyer
Organization
Buying history
- Records255 total
- Opportunities / awards10 / 19
- Value range$0 – $30,482,226
- ActiveJuly 15, 2026 – October 15, 2026
What they buy
- Clinical (243)
- Administrative (12)
Set-asides used
- No Set aside used (68)
- Small Business Set Aside - Total (13)
Who holds their work today
- EAGLE HEALTH, LLC1 win · $30,482,226 · last February 1, 2020
Also open from this buyer
- Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCRDue October 21, 2026 · Clinical
- NOI - Acquisition of orthopedic procedure for NHLBDue October 22, 2026 · Clinical
- NOI - A Non-Invasive Prognostic Biomarker - CirculDue October 23, 2026 · Clinical
- Notice of Intent to Sole Source – Guidehouse Digital LLC – Pediatric Oncology SupportDue October 19, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- No Set aside used
- NAICS
- 622110
- PSC
- Q201